You are here

The Future of the Glioma Market in the United States 2019-2024: Treatment Options, Pipeline Products, Epidemiology, Key Products Marketed, Market Valuations & Forecast, Drugs Sales, and Market Shares

DUBLIN, July 12, 2019 /PRNewswire/ -- The "US Glioma Market and Competitive Landscape - 2019" report has been added to's offering.

US Glioma Market and Competitive Landscape Highlights - 2019, provides comprehensive insights into Glioma pipeline products, Glioma epidemiology, Glioma market valuations and forecast, Glioma drugs sales and competitive landscape in the US.

The research is classified into seven sections - Glioma treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope

  • Glioma pipeline: Find out the products in clinical trials for the treatment of Glioma by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
  • Glioma epidemiology: Find out the number of patients diagnosed (prevalence) with Glioma in the US
  • Glioma drugs: Identify key products marketed and prescribed for Glioma in the US, including trade name, molecule name, and company
  • Glioma drugs sales: Find out the sales revenues of Glioma drugs in the US
  • Glioma market valuations: Find out the market size for Glioma drugs in 2018 in the US. Find out how the market advanced from 2014 and forecast to 2024
  • Glioma drugs market share: Find out the market shares for key Glioma drugs in the US

Benefits of this Research

  • Support monitoring and reporting national Glioma market analysis and sales trends
  • Track competitor drugs sales and market share in the US Glioma market
  • Track competitive developments in Glioma market and present key issues and learnings
  • Synthesize insights for Glioma market and products to drive business performance
  • Answer key business questions about the Glioma market
  • Evaluate commercial market opportunity assessment, positioning, and segmentation for Glioma products
  • Supports decision making in R&D to long term marketing strategies

Key Topics Covered
1) Glioma Treatments
2) Glioma Pipeline
3) US Glioma Epidemiology
4) Marketed Drugs for Glioma in US
5) US Glioma Market Size and Forecast
6) US Glioma Products Sales and Forecast
7) US Glioma Market Competitive Landscape
8) Methodology

List of Tables
1. Glioma Phase 3 Clinical Trials, 2019
2. Glioma Phase 2 Clinical Trials, 2019
3. Glioma Phase 1 Clinical Trials, 2019
4. Glioma Epidemiology, US, 2014 - 2024
5. Marketed Drugs for Glioma, US, 2018
6. Glioma Market Size and Forecast ($), US, 2014 - 2024
7. Glioma Product Sales ($), US, 2014 - 2024

List of Figures
1. Glioma Epidemiology, US, 2014 - 2024
2. Glioma Market Size and Forecast ($), US, 2014 - 2024
3. Glioma Products Market Share (%), US, 2018

For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:

SOURCE Research and Markets